| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 843 | 2.946 | 4.447 | 31.387 | 33.537 | 33.705 |
| Total Income - EUR | - | - | - | - | 843 | 2.946 | 5.256 | 31.388 | 33.538 | 33.781 |
| Total Expenses - EUR | - | - | - | - | 548 | 173 | 3.556 | 14.457 | 22.675 | 23.259 |
| Gross Profit/Loss - EUR | - | - | - | - | 295 | 2.773 | 1.700 | 16.930 | 10.863 | 10.522 |
| Net Profit/Loss - EUR | - | - | - | - | 274 | 2.722 | 1.542 | 16.466 | 10.527 | 10.184 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Migaroo Med Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 3.396 | 2.986 | 6.258 | 4.977 | 3.331 |
| Current Assets | - | - | - | - | 749 | 195 | 1.696 | 13.908 | 20.042 | 33.312 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 632 | 5 | 0 | 10.946 | 17.087 | 32.378 |
| Cash | - | - | - | - | 117 | 190 | 1.696 | 2.962 | 2.955 | 934 |
| Shareholders Funds | - | - | - | - | 317 | 3.033 | 4.508 | 19.441 | 23.844 | 33.895 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 432 | 558 | 175 | 726 | 1.174 | 2.748 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Migaroo Med Plus S.r.l.